aluates Reports

$ 0.0

Automative

Global Aluminum-based Vaccine Adjuvant Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-24L7657

Global Aluminum based Vaccine Adjuvant Market Insights and Forecast to 2028

BUY CHAPTERS

Global Aluminum-based Vaccine Adjuvant Market Research Report 2025

Code: QYRE-Auto-24L7657

Report

July 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Emergent Biosolutions

Sanofi

GlaxoSmithKline Biologicals

Pfizer Inc

Merck

Wyeth Pharmaceuticals

Aluminum-based Vaccine Adjuvant Market Size

The global market for Aluminum-based Vaccine Adjuvant was valued at US$ 485 million in the year 2024 and is projected to reach a revised size of US$ 661 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Aluminum-based Vaccine Adjuvant Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aluminum-based Vaccine Adjuvant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aluminum-based Vaccine Adjuvant.

The Aluminum-based Vaccine Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aluminum-based Vaccine Adjuvant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aluminum-based Vaccine Adjuvant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aluminum-based Vaccine Adjuvant Market Report

Report Metric	Details
Report Name	Aluminum-based Vaccine Adjuvant Market
Accounted market size in year	US$ 485 million
Forecasted market size in 2031	US$ 661 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Aluminium Potassium Sulfate Based Aluminum Phosphate Based Aluminum Hydroxide Based
Segment by Application	Dtap (diphtheria, Tetanus, Acellular Whooping Cough) Human Papillomavirus Pneumococcal Hepatitis A Hepatitis B Novel Coronavirus Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Pfizer, Merck, Wyeth Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aluminum-based Vaccine Adjuvant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aluminum-based Vaccine Adjuvant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Aluminum-based Vaccine Adjuvant Market growing?

Ans: The Aluminum-based Vaccine Adjuvant Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Aluminum-based Vaccine Adjuvant Market size in 2031?

Ans: The Aluminum-based Vaccine Adjuvant Market size in 2031 will be US$ 661 million.

Who are the main players in the Aluminum-based Vaccine Adjuvant Market report?

Ans: The main players in the Aluminum-based Vaccine Adjuvant Market are Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Pfizer, Merck, Wyeth Pharmaceuticals

What are the Application segmentation covered in the Aluminum-based Vaccine Adjuvant Market report?

Ans: The Applications covered in the Aluminum-based Vaccine Adjuvant Market report are Dtap (diphtheria, Tetanus, Acellular Whooping Cough), Human Papillomavirus, Pneumococcal, Hepatitis A, Hepatitis B, Novel Coronavirus, Other

What are the Type segmentation covered in the Aluminum-based Vaccine Adjuvant Market report?

Ans: The Types covered in the Aluminum-based Vaccine Adjuvant Market report are Aluminium Potassium Sulfate Based, Aluminum Phosphate Based, Aluminum Hydroxide Based

Recommended Reports

Vaccine Technologies

Vaccine Delivery & Storage

Pediatric & Preventable Vaccines

1 Aluminum-based Vaccine Adjuvant Market Overview

1.1 Product Definition

1.2 Aluminum-based Vaccine Adjuvant by Type

1.2.1 Global Aluminum-based Vaccine Adjuvant Market Value Comparison by Type (2024 VS 2031)

1.2.2 Aluminium Potassium Sulfate Based

1.2.3 Aluminum Phosphate Based

1.2.4 Aluminum Hydroxide Based

1.3 Aluminum-based Vaccine Adjuvant by Application

1.3.1 Global Aluminum-based Vaccine Adjuvant Market Value by Application (2024 VS 2031)

1.3.2 Dtap (diphtheria, Tetanus, Acellular Whooping Cough)

1.3.3 Human Papillomavirus

1.3.4 Pneumococcal

1.3.5 Hepatitis A

1.3.6 Hepatitis B

1.3.7 Novel Coronavirus

1.3.8 Other

1.4 Global Aluminum-based Vaccine Adjuvant Market Size Estimates and Forecasts

1.4.1 Global Aluminum-based Vaccine Adjuvant Revenue 2020-2031

1.4.2 Global Aluminum-based Vaccine Adjuvant Sales 2020-2031

1.4.3 Global Aluminum-based Vaccine Adjuvant Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Aluminum-based Vaccine Adjuvant Market Competition by Manufacturers

2.1 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Manufacturers (2020-2025)

2.2 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Aluminum-based Vaccine Adjuvant Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Aluminum-based Vaccine Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Product Type & Application

2.7 Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Date of Enter into This Industry

2.8 Global Aluminum-based Vaccine Adjuvant Market Competitive Situation and Trends

2.8.1 Global Aluminum-based Vaccine Adjuvant Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Aluminum-based Vaccine Adjuvant Players Market Share by Revenue

2.8.3 Global Aluminum-based Vaccine Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Aluminum-based Vaccine Adjuvant Market Scenario by Region

3.1 Global Aluminum-based Vaccine Adjuvant Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Aluminum-based Vaccine Adjuvant Sales by Region: 2020-2031

3.2.1 Global Aluminum-based Vaccine Adjuvant Sales by Region: 2020-2025

3.2.2 Global Aluminum-based Vaccine Adjuvant Sales by Region: 2026-2031

3.3 Global Aluminum-based Vaccine Adjuvant Revenue by Region: 2020-2031

3.3.1 Global Aluminum-based Vaccine Adjuvant Revenue by Region: 2020-2025

3.3.2 Global Aluminum-based Vaccine Adjuvant Revenue by Region: 2026-2031

3.4 North America Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country

3.4.1 North America Aluminum-based Vaccine Adjuvant Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Aluminum-based Vaccine Adjuvant Sales by Country (2020-2031)

3.4.3 North America Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country

3.5.1 Europe Aluminum-based Vaccine Adjuvant Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Aluminum-based Vaccine Adjuvant Sales by Country (2020-2031)

3.5.3 Europe Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Aluminum-based Vaccine Adjuvant Market Facts & Figures by Region

3.6.1 Asia Pacific Aluminum-based Vaccine Adjuvant Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Aluminum-based Vaccine Adjuvant Sales by Region (2020-2031)

3.6.3 Asia Pacific Aluminum-based Vaccine Adjuvant Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country

3.7.1 Latin America Aluminum-based Vaccine Adjuvant Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Aluminum-based Vaccine Adjuvant Sales by Country (2020-2031)

3.7.3 Latin America Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country

3.8.1 Middle East and Africa Aluminum-based Vaccine Adjuvant Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Aluminum-based Vaccine Adjuvant Sales by Country (2020-2031)

3.8.3 Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Aluminum-based Vaccine Adjuvant Sales by Type (2020-2031)

4.1.1 Global Aluminum-based Vaccine Adjuvant Sales by Type (2020-2025)

4.1.2 Global Aluminum-based Vaccine Adjuvant Sales by Type (2026-2031)

4.1.3 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Type (2020-2031)

4.2 Global Aluminum-based Vaccine Adjuvant Revenue by Type (2020-2031)

4.2.1 Global Aluminum-based Vaccine Adjuvant Revenue by Type (2020-2025)

4.2.2 Global Aluminum-based Vaccine Adjuvant Revenue by Type (2026-2031)

4.2.3 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Type (2020-2031)

4.3 Global Aluminum-based Vaccine Adjuvant Price by Type (2020-2031)

5 Segment by Application

5.1 Global Aluminum-based Vaccine Adjuvant Sales by Application (2020-2031)

5.1.1 Global Aluminum-based Vaccine Adjuvant Sales by Application (2020-2025)

5.1.2 Global Aluminum-based Vaccine Adjuvant Sales by Application (2026-2031)

5.1.3 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Application (2020-2031)

5.2 Global Aluminum-based Vaccine Adjuvant Revenue by Application (2020-2031)

5.2.1 Global Aluminum-based Vaccine Adjuvant Revenue by Application (2020-2025)

5.2.2 Global Aluminum-based Vaccine Adjuvant Revenue by Application (2026-2031)

5.2.3 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Application (2020-2031)

5.3 Global Aluminum-based Vaccine Adjuvant Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Emergent BioSolutions

6.1.1 Emergent BioSolutions Company Information

6.1.2 Emergent BioSolutions Description and Business Overview

6.1.3 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Product Portfolio

6.1.5 Emergent BioSolutions Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Aluminum-based Vaccine Adjuvant Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 GlaxoSmithKline Biologicals

6.3.1 GlaxoSmithKline Biologicals Company Information

6.3.2 GlaxoSmithKline Biologicals Description and Business Overview

6.3.3 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Product Portfolio

6.3.5 GlaxoSmithKline Biologicals Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Aluminum-based Vaccine Adjuvant Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Merck

6.5.1 Merck Company Information

6.5.2 Merck Description and Business Overview

6.5.3 Merck Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Merck Aluminum-based Vaccine Adjuvant Product Portfolio

6.5.5 Merck Recent Developments/Updates

6.6 Wyeth Pharmaceuticals

6.6.1 Wyeth Pharmaceuticals Company Information

6.6.2 Wyeth Pharmaceuticals Description and Business Overview

6.6.3 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Product Portfolio

6.6.5 Wyeth Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Aluminum-based Vaccine Adjuvant Industry Chain Analysis

7.2 Aluminum-based Vaccine Adjuvant Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Aluminum-based Vaccine Adjuvant Production Mode & Process Analysis

7.4 Aluminum-based Vaccine Adjuvant Sales and Marketing

7.4.1 Aluminum-based Vaccine Adjuvant Sales Channels

7.4.2 Aluminum-based Vaccine Adjuvant Distributors

7.5 Aluminum-based Vaccine Adjuvant Customer Analysis

8 Aluminum-based Vaccine Adjuvant Market Dynamics

8.1 Aluminum-based Vaccine Adjuvant Industry Trends

8.2 Aluminum-based Vaccine Adjuvant Market Drivers

8.3 Aluminum-based Vaccine Adjuvant Market Challenges

8.4 Aluminum-based Vaccine Adjuvant Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Sanofi

GlaxoSmithKline Biologicals

Pfizer Inc

Merck

Wyeth Pharmaceuticals

List of Tables

Table 1. Global Aluminum-based Vaccine Adjuvant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Aluminum-based Vaccine Adjuvant Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Aluminum-based Vaccine Adjuvant Market Competitive Situation by Manufacturers in 2024

Table 4. Global Aluminum-based Vaccine Adjuvant Sales (KG) of Key Manufacturers (2020-2025)

Table 5. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Aluminum-based Vaccine Adjuvant Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Aluminum-based Vaccine Adjuvant Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Aluminum-based Vaccine Adjuvant Average Price (US$/KG) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Aluminum-based Vaccine Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Product Type & Application

Table 12. Global Key Manufacturers of Aluminum-based Vaccine Adjuvant, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Aluminum-based Vaccine Adjuvant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aluminum-based Vaccine Adjuvant as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Aluminum-based Vaccine Adjuvant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Aluminum-based Vaccine Adjuvant Sales by Region (2020-2025) & (KG)

Table 18. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Region (2020-2025)

Table 19. Global Aluminum-based Vaccine Adjuvant Sales by Region (2026-2031) & (KG)

Table 20. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Region (2026-2031)

Table 21. Global Aluminum-based Vaccine Adjuvant Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Region (2020-2025)

Table 23. Global Aluminum-based Vaccine Adjuvant Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Region (2026-2031)

Table 25. North America Aluminum-based Vaccine Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Aluminum-based Vaccine Adjuvant Sales by Country (2020-2025) & (KG)

Table 27. North America Aluminum-based Vaccine Adjuvant Sales by Country (2026-2031) & (KG)

Table 28. North America Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Aluminum-based Vaccine Adjuvant Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Aluminum-based Vaccine Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Aluminum-based Vaccine Adjuvant Sales by Country (2020-2025) & (KG)

Table 32. Europe Aluminum-based Vaccine Adjuvant Sales by Country (2026-2031) & (KG)

Table 33. Europe Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Aluminum-based Vaccine Adjuvant Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Aluminum-based Vaccine Adjuvant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Aluminum-based Vaccine Adjuvant Sales by Region (2020-2025) & (KG)

Table 37. Asia Pacific Aluminum-based Vaccine Adjuvant Sales by Region (2026-2031) & (KG)

Table 38. Asia Pacific Aluminum-based Vaccine Adjuvant Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Aluminum-based Vaccine Adjuvant Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Aluminum-based Vaccine Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Aluminum-based Vaccine Adjuvant Sales by Country (2020-2025) & (KG)

Table 42. Latin America Aluminum-based Vaccine Adjuvant Sales by Country (2026-2031) & (KG)

Table 43. Latin America Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Aluminum-based Vaccine Adjuvant Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Aluminum-based Vaccine Adjuvant Sales by Country (2020-2025) & (KG)

Table 47. Middle East and Africa Aluminum-based Vaccine Adjuvant Sales by Country (2026-2031) & (KG)

Table 48. Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Aluminum-based Vaccine Adjuvant Sales (KG) by Type (2020-2025)

Table 51. Global Aluminum-based Vaccine Adjuvant Sales (KG) by Type (2026-2031)

Table 52. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Type (2020-2025)

Table 53. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Type (2026-2031)

Table 54. Global Aluminum-based Vaccine Adjuvant Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Aluminum-based Vaccine Adjuvant Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Type (2020-2025)

Table 57. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Type (2026-2031)

Table 58. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Type (2020-2025)

Table 59. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Type (2026-2031)

Table 60. Global Aluminum-based Vaccine Adjuvant Sales (KG) by Application (2020-2025)

Table 61. Global Aluminum-based Vaccine Adjuvant Sales (KG) by Application (2026-2031)

Table 62. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Application (2020-2025)

Table 63. Global Aluminum-based Vaccine Adjuvant Sales Market Share by Application (2026-2031)

Table 64. Global Aluminum-based Vaccine Adjuvant Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Aluminum-based Vaccine Adjuvant Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Application (2020-2025)

Table 67. Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Application (2026-2031)

Table 68. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Application (2020-2025)

Table 69. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Application (2026-2031)

Table 70. Emergent BioSolutions Company Information

Table 71. Emergent BioSolutions Description and Business Overview

Table 72. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 73. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Product

Table 74. Emergent BioSolutions Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 78. Sanofi Aluminum-based Vaccine Adjuvant Product

Table 79. Sanofi Recent Developments/Updates

Table 80. GlaxoSmithKline Biologicals Company Information

Table 81. GlaxoSmithKline Biologicals Description and Business Overview

Table 82. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 83. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Product

Table 84. GlaxoSmithKline Biologicals Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 88. Pfizer Aluminum-based Vaccine Adjuvant Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Merck Company Information

Table 91. Merck Description and Business Overview

Table 92. Merck Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 93. Merck Aluminum-based Vaccine Adjuvant Product

Table 94. Merck Recent Developments/Updates

Table 95. Wyeth Pharmaceuticals Company Information

Table 96. Wyeth Pharmaceuticals Description and Business Overview

Table 97. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)

Table 98. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Product

Table 99. Wyeth Pharmaceuticals Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Aluminum-based Vaccine Adjuvant Distributors List

Table 103. Aluminum-based Vaccine Adjuvant Customers List

Table 104. Aluminum-based Vaccine Adjuvant Market Trends

Table 105. Aluminum-based Vaccine Adjuvant Market Drivers

Table 106. Aluminum-based Vaccine Adjuvant Market Challenges

Table 107. Aluminum-based Vaccine Adjuvant Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Aluminum-based Vaccine Adjuvant

Figure 2. Global Aluminum-based Vaccine Adjuvant Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Aluminum-based Vaccine Adjuvant Market Share by Type: 2024 & 2031

Figure 4. Aluminium Potassium Sulfate Based Product Picture

Figure 5. Aluminum Phosphate Based Product Picture

Figure 6. Aluminum Hydroxide Based Product Picture

Figure 7. Global Aluminum-based Vaccine Adjuvant Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Aluminum-based Vaccine Adjuvant Market Share by Application: 2024 & 2031

Figure 9. Dtap (diphtheria, Tetanus, Acellular Whooping Cough)

Figure 10. Human Papillomavirus

Figure 11. Pneumococcal

Figure 12. Hepatitis A

Figure 13. Hepatitis B

Figure 14. Novel Coronavirus

Figure 15. Other

Figure 16. Global Aluminum-based Vaccine Adjuvant Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Aluminum-based Vaccine Adjuvant Market Size (2020-2031) & (US$ Million)

Figure 18. Global Aluminum-based Vaccine Adjuvant Sales (2020-2031) & (KG)

Figure 19. Global Aluminum-based Vaccine Adjuvant Average Price (US$/KG) & (2020-2031)

Figure 20. Aluminum-based Vaccine Adjuvant Report Years Considered

Figure 21. Aluminum-based Vaccine Adjuvant Sales Share by Manufacturers in 2024

Figure 22. Global Aluminum-based Vaccine Adjuvant Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Aluminum-based Vaccine Adjuvant Players: Market Share by Revenue in Aluminum-based Vaccine Adjuvant in 2024

Figure 24. Aluminum-based Vaccine Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Aluminum-based Vaccine Adjuvant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Aluminum-based Vaccine Adjuvant Sales Market Share by Country (2020-2031)

Figure 27. North America Aluminum-based Vaccine Adjuvant Revenue Market Share by Country (2020-2031)

Figure 28. United States Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Aluminum-based Vaccine Adjuvant Sales Market Share by Country (2020-2031)

Figure 31. Europe Aluminum-based Vaccine Adjuvant Revenue Market Share by Country (2020-2031)

Figure 32. Germany Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Aluminum-based Vaccine Adjuvant Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Aluminum-based Vaccine Adjuvant Revenue Market Share by Region (2020-2031)

Figure 39. China Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Aluminum-based Vaccine Adjuvant Sales Market Share by Country (2020-2031)

Figure 49. Latin America Aluminum-based Vaccine Adjuvant Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Aluminum-based Vaccine Adjuvant Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. UAE Aluminum-based Vaccine Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Aluminum-based Vaccine Adjuvant by Type (2020-2031)

Figure 59. Global Revenue Market Share of Aluminum-based Vaccine Adjuvant by Type (2020-2031)

Figure 60. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Type (2020-2031)

Figure 61. Global Sales Market Share of Aluminum-based Vaccine Adjuvant by Application (2020-2031)

Figure 62. Global Revenue Market Share of Aluminum-based Vaccine Adjuvant by Application (2020-2031)

Figure 63. Global Aluminum-based Vaccine Adjuvant Price (US$/KG) by Application (2020-2031)

Figure 64. Aluminum-based Vaccine Adjuvant Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine Digital Data Logger Market Insights Forecast to 2030

Global Vaccine Particulate Adjuvants Market Research Report 2025

Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine Cooler Market Research Report 2025

Global Attenuated Vaccine Market Research Report 2025

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peanut Allergy Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Paediatric Vaccine Market

Inactivated Influenza Vaccine Market

Global Livestock Vaccine Market Research Report 2025

Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Packaging Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Trivalent Flu Vaccine Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions